Big Pharma's Corporate Venture Arm Flexes in Life Science Investing

Date: Thursday, September 22nd, 2011

 

Street Address: Orrick, Herrington & Sutcliffe LLP, 1000 Marsh Road, Building 1100, Menlo Park, CA 94025-1015

 

Quick Description: The significant costs, extended timelines, and regulatory hurdles facing emerging life science companies in today's economy make it increasingly difficult for VCs to make a sizable return on their investment. Can the same be said for corporate investors, or do they have different objectives? What is driving their investment strategy? Is it strategic alignment, an attempt at harnessing innovation, or simply good business? Join us at our next industry panel for an interactive discussion on why and how corporate players are getting in the game and hitting it big! Could this be the changing of the guard in life sciences? Our Panel discussions are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself. This Panel will be followed by a Networking Reception.

http://www.sjbiocenter.com/event/ev_2011Q3-COG-InvestinginLifeSciences.html

 

Link for more Info & Registration: http://investlifesci-webs.eventbrite.com/

Location

Orrick, Herrington & Sutcliffe LLP, 1000 Marsh Road, Building 1100, Menlo Park, CA 94025-1015

Contact Information

http://investlifesci-webs.eventbrite.com/